Welcome to our dedicated page for MODEL N news (Ticker: MODN), a resource for investors and traders seeking the latest updates and insights on MODEL N stock.
Model N, Inc. (NYSE: MODN) is a leader in cloud-based revenue management solutions that transform complex business processes into streamlined operations. The company’s mission is to drive essential business processes such as configure, price, and quote (CPQ), contract and rebate management, business intelligence, and regulatory compliance. This transformation is achieved by turning the revenue lifecycle from a series of disconnected operations into a cohesive, end-to-end strategic process.
Model N caters to life sciences, technology, and manufacturing industries, providing solutions that meet the complex needs of some of the world's leading brands, including Johnson & Johnson, AstraZeneca, Boston Scientific, Novartis, Microchip Technology, and ON Semiconductor. Its offerings are utilized in over 100 countries, ensuring robust global reach and impact.
The company's flagship products include the Revenue Cloud for Life Sciences and the Revenue Cloud for High Tech. These platforms are designed to enhance revenue and operational efficiency while complying with stringent regulatory requirements. They enable the creation and execution of contracts, modernize sales processes, and strategically manage the revenue lifecycle.
Model N has recently launched Price Management, a new solution aimed at semiconductor, electronic component, and high-tech manufacturers to manage price execution across various sales channels globally. This solution integrates with Model N's Deal Management to provide a comprehensive pricing update system, ensuring real-time data alignment with market realities and regulatory compliance.
Additionally, the company's 2024 State of Revenue Report highlights the priorities and challenges faced by executives in pharmaceutical, medical technology, and high-tech manufacturing sectors. Key findings include the emphasis on advanced analytics and AI to improve process efficiency and cost-saving measures, while addressing issues like supply chain disruptions and regulatory changes.
Model N is currently undergoing a significant transition, with a pending acquisition by Vista Equity Partners, announced in April 2024. Despite this, the company remains focused on its core mission, providing innovative solutions to drive revenue optimization and compliance for its esteemed clientele.
For more information, visit www.modeln.com.
Model N, Inc. (NYSE: MODN) celebrated its 10th anniversary as a public company by ringing the New York Stock Exchange opening bell on March 24. The company focuses on revenue optimization and compliance for the life sciences and high-tech sectors, helping brands to bring products to market effectively. CEO Jason Blessing emphasized the firm’s momentum and commitment to customer success. Model N's culture, driven by its DARE values—Dream, Align, Respect, and Excel—is cited as a cornerstone of its innovation and performance. The company is trusted by major players like Johnson & Johnson and AstraZeneca.
Model N, Inc. (NYSE: MODN) has released a commissioned study by Forrester Consulting, highlighting the critical need for advanced channel data management (CDM) in optimizing revenue processes. The report illustrates that 63% of decision-makers plan to invest in channel revenue management in the coming year. Key findings reveal that firms struggle with data challenges, emphasizing the importance of automated solutions for enhanced trust and profitability. A significant 3 in 5 respondents noted the value of automating CDM to drive better results. Decision-makers are urged to invest in systems that ensure accurate data management for improved operational outcomes.
Model N, Inc. (NYSE: MODN) has announced the pricing of $220 million in convertible senior notes due 2028, aimed at qualified institutional buyers. The offering includes an option for initial purchasers to buy an additional $33 million. Proceeds will be used to repurchase $138 million of existing 2.625% convertible notes due 2025 and for other corporate needs. The initial conversion price is set at approximately $43.04 per share, a 32.5% premium over the last recorded price of $32.48. The notes are unsecured and will mature on March 15, 2028, with specific conditions for conversion prior to this date.
Model N, Inc. (NYSE: MODN) announced its intention to offer $220.0 million of convertible senior notes due 2028 in a private placement for qualified institutional buyers. The company may grant initial purchasers an option to buy an additional $33.0 million in notes. Interest will be payable semi-annually, and the notes can be converted under specific conditions. Model N plans to use proceeds for repurchasing existing convertible notes and for general corporate purposes. The press release highlights certain risks related to the offering and emphasizes that the announcement does not constitute a sale or solicitation of securities.
Model N, Inc. (NYSE: MODN) announced that CEO Jason Blessing and CFO John Ederer will present at the JMP Securities Technology Conference on March 6, 2023, at 8:30 a.m. PT. A webcast of the presentation will be available on the company's investor relations page. Model N specializes in revenue optimization and compliance for pharmaceutical, medtech, and high-tech sectors, automating pricing and contract decisions. Trusted by major companies worldwide, including Johnson & Johnson and AstraZeneca, Model N supports digital transformation through its integrated cloud solutions.
Model N, Inc. (NYSE: MODN) reported a 15% year-over-year revenue growth for Q1 FY2023, totaling $59.2 million, driven by a 36% increase in SaaS ARR, reaching an all-time high of $115.8 million. Subscription revenues rose by 16% to $44.2 million. Net loss decreased 35% to $4.1 million, with a non-GAAP net income of $8.7 million, up 61%. Adjusted EBITDA grew 27% to $9.1 million, reflecting a margin of 15%. The company provided Q2 FY2023 revenue guidance of $59.0 to $60.0 million and a full-year guidance of $242.0 to $245.0 million, indicating continued optimism for profitable growth.
Model N (NYSE:MODN) released its fifth annual State of Revenue Report, highlighting challenges faced by pharmaceutical and high-tech sectors. Key issues include supply chain disruption (43%) and inflation (84%) impacting revenue optimization. The report indicates that 70% of executives believe poor revenue management costs billions, emphasizing the need for technology investments. Compliance remains a crucial concern, with 97% of pharma executives preparing for regulatory changes. Despite these challenges, 98% of respondents are optimistic about future industry conditions with upcoming legislation like the CHIPS Act.
Model N, Inc. (NYSE: MODN) is set to host its annual State of Revenue webinars on February 7, 2023, at 11 a.m. ET and 1 p.m. ET. This event coincides with the release of the company’s fifth annual State of Revenue Report, which gathers insights from executives in high-tech, semiconductor, pharmaceutical, and medical technology sectors. Presenters will discuss the evolution of revenue management teams and the role of technology in optimizing revenue and compliance processes.
Notable speakers include Jesse Mendelsohn and Gloria Kee from Model N. The report covers key trends and challenges in revenue optimization amidst changing market conditions.
Model N, Inc. (NYSE: MODN) will report its financial results for Q1 FY 2023 on February 7, 2023, after market close. A conference call is scheduled for 2:00 PM PT to discuss the results and business outlook. Investors can access the call by dialing 877-407-4018 in the U.S. or +1-201-689-8471 internationally. A live webcast will be available on the company’s investor relations page, with a replay accessible until 11:59 PM ET on February 21, 2023. Model N specializes in revenue optimization and compliance for various industries, utilizing a cloud platform to enhance business profits.
Model N, Inc. (NYSE: MODN) has announced its Fall 2022 product release of the Model N Revenue Cloud, focusing on revenue optimization and compliance for life sciences and high-tech sectors. The update offers enhancements aimed at improving profitability and strategic objectives for pharmaceutical and medtech companies, including better revenue forecasting and Medicaid rebate calculations. Additionally, high-tech firms benefit from a 25% improvement in rebate calculation performance. These enhancements are designed to help clients quickly adapt to market changes amid rising economic pressures.
FAQ
What is the current stock price of MODEL N (MODN)?
What is the market cap of MODEL N (MODN)?
What does Model N, Inc. specialize in?
What are the main products offered by Model N?
Which industries does Model N serve?
What is the latest product launched by Model N?
What is Model N’s 2024 State of Revenue Report about?
Where does Model N generate most of its revenue?
Who are some of Model N’s notable clients?
What significant corporate event is Model N currently undergoing?
How does Model N address regulatory compliance for pharmaceuticals?